Minocycline 65mg ER Tablets

Minocycline 65mg is an extended-release tetracycline-class antibiotic used for inflammatory lesions of moderate to severe acne. This acne-focused release formulation should not be assumed interchangeable with standard minocycline used for other bacterial infections.
Swallow the extended-release tablet whole with a full glass of water and remain upright afterwards. It can be taken with or without food; food may reduce oesophageal irritation. Separate iron, zinc and aluminium-, calcium- or magnesium-containing supplements and antacids.
Minocycline inhibits bacterial protein synthesis at the 30S ribosome. Its benefit in acne also involves anti-inflammatory effects; the exact contribution of each mechanism is not fully established.
Dizziness, vertigo, headache, nausea and pigmentation changes can occur. Severe headache with visual disturbance, jaundice, widespread rash or joint pain with fever requires prompt assessment.
Do not combine casually with isotretinoin because of intracranial-pressure risk. Pregnancy and developing teeth are important concerns. Serious autoimmune or hypersensitivity reactions are possible. Prolonged antibiotic exposure should not replace a complete acne treatment strategy.
Can reduce inflamed acne lesions while providing gradual minocycline delivery in an acne-specific formulation.
No. Extended-release acne formulations have specific clinical evidence and should not automatically inherit all uses of immediate-release minocycline.
Not automatically. Release characteristics and exposure differ, even when the active ingredient is the same.
Minocycline can produce vestibular adverse effects, particularly dizziness or vertigo.
It treats active inflammatory lesions, not established scar tissue.
Both medicines are associated with intracranial hypertension, and combined use increases concern.
Inflammatory acne: acne with red papules, pustules or deeper inflamed lesions. Vestibular effect: an effect on balance or motion sensation. Intracranial hypertension: increased pressure around the brain. Extended release: gradual drug delivery; AR: Minocycline 65mg أقراص ممتدة التحرر; FR: Minocycline 65mg comprimés à libération prolongée; PT: Minocycline 65mg comprimidos de libertação prolongada; ES: Minocycline 65mg comprimidos de liberación prolongada; RU: Minocycline 65mg таблетки пролонгированного высвобождения; ID: Minocycline 65mg tablet lepas lambat; VI: Minocycline 65mg viên nén giải phóng kéo dài; MS: Minocycline 65mg tablet pelepasan berpanjangan; TL: Minocycline 65mg tabletang may pinalawig na paglabas; ZH-SG: Minocycline 65mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Minocycline 65mg ER Tablets under Antibiotics. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Minocycline 65mg ER Tablets